Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus development conference statement

J. T. Potts, I. P. Ackerman, C. F. Barker, M. F. Brennan, J. W. Coburn, S. L. Hui, G. L. Melson, L. G. Raisz, M. Rosenblatt, C. T. Rubin, J. A. Schlechte, J. L. Townsend, L. K. Wolfe, G. L. Wong

Research output: Contribution to journalArticle

457 Citations (Scopus)

Abstract

Endocrinologists, surgeons, radiologists, epidemiologists, and primary health care providers convened to address both indications for surgery in asymptomatic patients with hyperparathyroidism as well as how patients who do not have surgery should be monitored and managed to minimize the risk for complications. The National Institutes of Health Consensus Development Conference Panel concluded that a diagnosis of hyperparathyroidism is established by showing persistent hypercalcemia and an elevated serum parathyroid hormone concentration; that the current and acceptable treatment for hyperparathyroidism is surgery; that the diagnosis of hyperparathyroidism in an asymptomatic patient does not in all cases mandate referral for surgery; that conscientious surveillance may be justified in patients whose calcium levels are only mildly elevated and whose renal and bone status are close to normal; and that preoperative localization in patients without previous neck operation is rarely indicated and has not proved to be cost effective.

Original languageEnglish (US)
Pages (from-to)593-597
Number of pages5
JournalAnnals of internal medicine
Volume114
Issue number7
DOIs
StatePublished - Jan 1 1991

Fingerprint

Consensus Development Conferences
Primary Hyperparathyroidism
Hyperparathyroidism
National Institutes of Health (U.S.)
Hypercalcemia
Parathyroid Hormone
Health Personnel
Primary Health Care
Neck
Referral and Consultation
Calcium
Kidney
Costs and Cost Analysis
Bone and Bones
Serum

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Diagnosis and management of asymptomatic primary hyperparathyroidism : Consensus development conference statement. / Potts, J. T.; Ackerman, I. P.; Barker, C. F.; Brennan, M. F.; Coburn, J. W.; Hui, S. L.; Melson, G. L.; Raisz, L. G.; Rosenblatt, M.; Rubin, C. T.; Schlechte, J. A.; Townsend, J. L.; Wolfe, L. K.; Wong, G. L.

In: Annals of internal medicine, Vol. 114, No. 7, 01.01.1991, p. 593-597.

Research output: Contribution to journalArticle

Potts, JT, Ackerman, IP, Barker, CF, Brennan, MF, Coburn, JW, Hui, SL, Melson, GL, Raisz, LG, Rosenblatt, M, Rubin, CT, Schlechte, JA, Townsend, JL, Wolfe, LK & Wong, GL 1991, 'Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus development conference statement', Annals of internal medicine, vol. 114, no. 7, pp. 593-597. https://doi.org/10.7326/0003-4819-114-7-593
Potts, J. T. ; Ackerman, I. P. ; Barker, C. F. ; Brennan, M. F. ; Coburn, J. W. ; Hui, S. L. ; Melson, G. L. ; Raisz, L. G. ; Rosenblatt, M. ; Rubin, C. T. ; Schlechte, J. A. ; Townsend, J. L. ; Wolfe, L. K. ; Wong, G. L. / Diagnosis and management of asymptomatic primary hyperparathyroidism : Consensus development conference statement. In: Annals of internal medicine. 1991 ; Vol. 114, No. 7. pp. 593-597.
@article{e1f8f01e7ee74b188f59747568c1ad1e,
title = "Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus development conference statement",
abstract = "Endocrinologists, surgeons, radiologists, epidemiologists, and primary health care providers convened to address both indications for surgery in asymptomatic patients with hyperparathyroidism as well as how patients who do not have surgery should be monitored and managed to minimize the risk for complications. The National Institutes of Health Consensus Development Conference Panel concluded that a diagnosis of hyperparathyroidism is established by showing persistent hypercalcemia and an elevated serum parathyroid hormone concentration; that the current and acceptable treatment for hyperparathyroidism is surgery; that the diagnosis of hyperparathyroidism in an asymptomatic patient does not in all cases mandate referral for surgery; that conscientious surveillance may be justified in patients whose calcium levels are only mildly elevated and whose renal and bone status are close to normal; and that preoperative localization in patients without previous neck operation is rarely indicated and has not proved to be cost effective.",
author = "Potts, {J. T.} and Ackerman, {I. P.} and Barker, {C. F.} and Brennan, {M. F.} and Coburn, {J. W.} and Hui, {S. L.} and Melson, {G. L.} and Raisz, {L. G.} and M. Rosenblatt and Rubin, {C. T.} and Schlechte, {J. A.} and Townsend, {J. L.} and Wolfe, {L. K.} and Wong, {G. L.}",
year = "1991",
month = "1",
day = "1",
doi = "10.7326/0003-4819-114-7-593",
language = "English (US)",
volume = "114",
pages = "593--597",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "7",

}

TY - JOUR

T1 - Diagnosis and management of asymptomatic primary hyperparathyroidism

T2 - Consensus development conference statement

AU - Potts, J. T.

AU - Ackerman, I. P.

AU - Barker, C. F.

AU - Brennan, M. F.

AU - Coburn, J. W.

AU - Hui, S. L.

AU - Melson, G. L.

AU - Raisz, L. G.

AU - Rosenblatt, M.

AU - Rubin, C. T.

AU - Schlechte, J. A.

AU - Townsend, J. L.

AU - Wolfe, L. K.

AU - Wong, G. L.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Endocrinologists, surgeons, radiologists, epidemiologists, and primary health care providers convened to address both indications for surgery in asymptomatic patients with hyperparathyroidism as well as how patients who do not have surgery should be monitored and managed to minimize the risk for complications. The National Institutes of Health Consensus Development Conference Panel concluded that a diagnosis of hyperparathyroidism is established by showing persistent hypercalcemia and an elevated serum parathyroid hormone concentration; that the current and acceptable treatment for hyperparathyroidism is surgery; that the diagnosis of hyperparathyroidism in an asymptomatic patient does not in all cases mandate referral for surgery; that conscientious surveillance may be justified in patients whose calcium levels are only mildly elevated and whose renal and bone status are close to normal; and that preoperative localization in patients without previous neck operation is rarely indicated and has not proved to be cost effective.

AB - Endocrinologists, surgeons, radiologists, epidemiologists, and primary health care providers convened to address both indications for surgery in asymptomatic patients with hyperparathyroidism as well as how patients who do not have surgery should be monitored and managed to minimize the risk for complications. The National Institutes of Health Consensus Development Conference Panel concluded that a diagnosis of hyperparathyroidism is established by showing persistent hypercalcemia and an elevated serum parathyroid hormone concentration; that the current and acceptable treatment for hyperparathyroidism is surgery; that the diagnosis of hyperparathyroidism in an asymptomatic patient does not in all cases mandate referral for surgery; that conscientious surveillance may be justified in patients whose calcium levels are only mildly elevated and whose renal and bone status are close to normal; and that preoperative localization in patients without previous neck operation is rarely indicated and has not proved to be cost effective.

UR - http://www.scopus.com/inward/record.url?scp=0025825750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025825750&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-114-7-593

DO - 10.7326/0003-4819-114-7-593

M3 - Article

C2 - 1900404

AN - SCOPUS:0025825750

VL - 114

SP - 593

EP - 597

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 7

ER -